The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change.

To overcome barriers to biologic care for patients with asthma, personalized treatment is key, according to a speaker at the 16th Annual Allergy, Asthma & Immunology CME Conference.

Among patients with severe asthma, treatment with biologics was associated with improved asthma outcomes across all age groups, according to results presented at the American Academy of Allergy ...

-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized trial. JAMA 2001; 285: 2583-2593 One hundred sixty-four patients with ...

Asthma biologics commenced before conception can be continued throughout pregnancy, including the third trimester [with the exception for tezepelumab]." Postpartum care: "9.

Asthma Highlights From ACAAI 2021 From ACAAI 2021, Dr Sandhya Khurana reports on advances in asthma, including novel biologic therapies, burden of corticosteroid use, and racial differences in ...

SAN ANTONIO — Personalized treatment strategies can help providers overcome barriers to biologic care for patients with asthma, Lukena Karkhanis, MD, said at the 16th Annual Allergy, ...

While using biologics, upto 50 percent of patients have complete relief from symptoms, asthma flare ups and need of oral steroids, and these people are known to have achieved ‘Clinical Remission’.

Poorly controlled asthma during pregnancy can lead to serious complications, such as low birth weight, preterm delivery, and preeclampsia. For individuals with severe asthma, biologics—a new ...

Annualized asthma exacerbation rates were compared by age group (18-49, 50-64, ≥65 years) and by biologic type (anti-immunoglobulin E [IgE] vs other biologics [anti-interleukin-5/5R/4Rs or ...